Moreover, among the four types of breast cancer cell lines with different metastatic abilities, the expression of MAP7D1 was higher in two aggressive cell lines (MDA-MB-231 and MDA-MB-453), and lower in two less aggressive cell lines (MCF7 and T47D) (Figure S8A). This evidence concerns the gene MAP7D1 and breast carcinoma.